|
Volumn 98, Issue 20, 2001, Pages 11545-11550
|
Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
TUMOR VACCINE;
VASCULOTROPIN;
ANGIOGENESIS;
ANTIGEN SPECIFICITY;
ARTICLE;
CANCER THERAPY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENE TARGETING;
GENE THERAPY;
GENOME;
IMMUNOGENETICS;
IMMUNOLOGICAL TOLERANCE;
NONHUMAN;
PRIORITY JOURNAL;
TUMOR GROWTH;
TUMOR IMMUNITY;
XENOPUS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ENDOTHELIAL GROWTH FACTORS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FIBROSARCOMA;
GENE LIBRARY;
IMMUNOHISTOCHEMISTRY;
IMMUNOTHERAPY;
KILLER CELLS, NATURAL;
LIVER NEOPLASMS, EXPERIMENTAL;
LYMPHOCYTE DEPLETION;
LYMPHOCYTE SUBSETS;
LYMPHOKINES;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MODELS, IMMUNOLOGICAL;
T-LYMPHOCYTES;
TUMOR CELLS, CULTURED;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
XENOPUS LAEVIS;
|
EID: 0035949593
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.191112198 Document Type: Article |
Times cited : (129)
|
References (51)
|